Targeting the stimulator of interferon genes (STING) in breast cancer

Breast cancer has a high occurrence rate globally and its treatment has demonstrated clinical efficacy with the use of systemic chemotherapy and immune checkpoint blockade. Insufficient cytotoxic T lymphocyte infiltration and the accumulation of immunosuppressive cells within tumours are the primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying-Rui, Ma, Bu-Fan, Bai, Deng, Liu, Rong, Shi, Qian-Mei, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338072/
https://www.ncbi.nlm.nih.gov/pubmed/37448962
http://dx.doi.org/10.3389/fphar.2023.1199152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338072/
https://www.ncbi.nlm.nih.gov/pubmed/37448962
http://dx.doi.org/10.3389/fphar.2023.1199152

Ejemplares similares